brasil peptideos melanotan 2 Melanotan II MT-II Research Peptide
Description
Both of these classes share identical attributes
Acetyl-L-carnitine augmentation of clozapine in partial-responder schizophrenia: a 12-week, open-label uncontrolled preliminary study
Although there was a high rate of adverse effects (27%), 39% had a favorable on-treatment response and 21% developed an SVR (11% in genotype 1 and 50% in genotype 2 and 3), all of whom remained virus-free post-transplantation
PMID 17584135
The peptide itself doesn't 'stay in your system' in the conventional sense
